Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2025-05-05 00:00:00 ET · period of report 2025-05-01 · accession 0000875320-25-000177 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-05 | 2025-05-01 | VRTX | Garber Alan M | Dir | A - Grant | $0.00 | +398 | 6,872 | +6% | $0 |
| D | 2025-05-05 | 2025-05-01 | VRTX | Garber Alan M | Dir | A - Grant | $0.00 | +1,199 | 1,199 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-01 | A | A | 398 | $0.00 | 6,872 | D | — | — | (F1) Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-05-01 | A | A | 1,199 | $0.00 | 1,199 | D | $502.97 · — to 2035-04-30 | 1,199 Common Stock | (F2) Fully vested. |